Diagnosis at stages 1-3 increases cancer survival rate significantly
pharmafile | January 25, 2019 | News story | Medical Communications | Cancer, England, NHS, health, oncology
Adults diagnosed with stage 1 skin, prostate or breast cancer have the same chance of still being alive the following year as the average person, according to data from the Office for National Statistics and Public Health England.
Survival rates are high for many cancers if diagnosed in stages 1-3, the data shows. However cancers diagnosed in stage four have lower survival rates. Pancreatic cancer has the lowest rate of survival in both men and women.
Significantly, 90% of women diagnosed with breast cancer will survive for a year, if they are diagnosed at stages 1-3. However survival rates drop to 66%, when women are diagnosed at stage 4.
Meanwhile nearly 100% of men diagnosed with prostate cancer at stages 1-3 survive compared to 87.6% of those diagnosed at stage 4.
Skin cancer was found to have the highest one year survival rate at stages 1-4 with 97.4% of men and 98.6% of women surviving for a year.
Sarah Caul, head of cancer analysis at the ONS, commented: “This research shows a mixed picture but does stress the need for awareness and early diagnosis.”
Overall cancer survival rates have been increasingly steadily in England since 2006.
Louis Goss
Related Content
IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer
Precision medicine oncology company IDEAYA Biosciences has announced that the first patient in the IDEAYA-sponsored …
Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA
The US Food and Drug Administration (FDA) has granted an expanded Orphan Drug Designation (ODD) …
OSE Immunotherapeutics and Boehringer Ingelheim collaborate on cancer and cardio-renal-metabolic disease treatments
OSE Immunotherapeutics and Boehringer Ingelheim have announced a major expansion of their existing partnership. The …